Skip to main content
SR biotek Inc. logo

SR biotek Inc. — Investor Relations & Filings

Ticker · 270210 ISIN · KR7270210008 KO Manufacturing
Open in API
Filings indexed 190 across all filing types
Latest filing 2018-11-13 Regulatory Filings
Country KR South Korea
Listing KO 270210

About SR biotek Inc.

http://srbiotek.com/

SR biotek Inc. is a biotechnology and cosmeceutical company specializing in the research, development, and manufacturing of innovative skincare products. The company offers comprehensive turnkey OEM/ODM solutions to its partners, covering product development, quality control, and manufacturing. A core strength lies in the development of novel ingredients, highlighted by its proprietary bio-material, RAPHITOX, which utilizes a micro-needle shaped structure. In addition to its manufacturing services, SR biotek also develops its own branded skincare lines.

Recent filings

Filing Released Lang Actions
불성실공시법인지정(공시번복)
Regulatory Filings Classification · 95% confidence The document is a regulatory notice regarding the designation of the company as an 'unfaithful disclosure corporation' (불성실공시법인) due to the cancellation of a shareholder meeting resolution. This is a specific regulatory announcement regarding compliance and disclosure violations, which falls under the general regulatory filing category.
2018-11-13 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report or major shareholding notification). It details the changes in share ownership by Anda Asset Management in the company SR Biotech. This document type corresponds to the 'Major Shareholding Notification' category.
2018-11-09 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement regarding the results of a securities issuance (specifically, redeemable convertible preferred shares via third-party allocation). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2018-11-08 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 95% confidence The document is a short, structured announcement (under 1,000 characters) detailing the results of an Investor Relations (IR) event held by SR Biotech. It lists the date, location, attendees, and agenda of the meeting. Since it is a brief notification of an event that has occurred rather than the full presentation deck or a comprehensive financial report, it falls under the category of a regulatory announcement regarding corporate activities.
2018-11-08 Korean
기타주요경영사항
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from SR Biotech regarding the cancellation of a previously scheduled Extraordinary General Meeting (EGM). It does not contain the full proxy materials or the results of a vote, but rather serves as a formal notice of a corporate governance decision. Since it is a regulatory announcement that does not fit into specific categories like AGM-R or DVA, it falls under the general regulatory filing category.
2018-11-06 Korean
불성실공시법인지정예고(공시번복)
Regulatory Filings Classification · 95% confidence The document is a formal notice from a regulatory body (Konex market) regarding the 'pre-designation of an unfaithful disclosure corporation' due to a disclosure reversal (cancellation of a shareholder meeting resolution). This is a regulatory announcement concerning compliance and legal/regulatory status, which fits the 'Regulatory Filings' (RNS) category as it does not represent a financial report, dividend, or specific corporate action like M&A or share issuance.
2018-11-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.